Question 1

What is the catalog number for PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued?

Accepted Answer

The catalog number for PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued is P3113-83J2-FITC.

Question 2

What sizes are available for PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued?

Accepted Answer

PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued is available in the following size(s): 200 µL.

Question 3

Is PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued in stock?

Accepted Answer

PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 5

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Question 6

What is the recommended incubation time for this antibody?

Accepted Answer

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

PAX3, NT (Paired Box Protein Pax-3, HUP2) (FITC) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

FITC Conjugated Human CD200 Recombinant Rabbit Monoclonal Antibody [PSH01-48]

CLEC9A / DNGR1 (Dendritic Cell Marker) (8F9), CF740 conjugate, 0.1mg/mL

HLA-DR (MHC II) (TAL 1B5), CF740 conjugate, 0.1mg/mL

Anti-GABARAP Antibody Picoband®

CD50 (ICAM-3) (ICAM3/1019), CF640R conjugate, 0.1mg/mL

ZIP Kinase Recombinant Rabbit Monoclonal Antibody [PSH02-18]